Results 1 to 10 of about 5,118 (209)

Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency [PDF]

open access: yesCellular Physiology and Biochemistry, 2017
Background/Aims: Mevalonate Kinase Deficiency (MKD), is a hereditary disease due to mutations in mevalonate kinase gene (MVK). MKD has heterogeneous clinical phenotypes: the correlation between MVK mutations and MKD clinical phenotype is still to be ...
Paola Maura Tricarico   +4 more
doaj   +3 more sources

A Requirement of Protein Geranylgeranylation for Chemokine Receptor Signaling and Th17 Cell Function in an Animal Model of Multiple Sclerosis

open access: yesFrontiers in Immunology, 2021
Precisely controlled lymphocyte migration is critically required for immune surveillance and successful immune responses. Lymphocyte migration is strictly regulated by chemokines and chemokine receptors.
Gregory Swan   +11 more
doaj   +3 more sources

The structural basis for synergistic inhibition of geranylgeranyl diphosphate synthase with stereoisomeric triazole bisphosphonates [PDF]

open access: yesStructural Dynamics
Several incurable cancers are characterized by abnormal protein production and secretion. A prime example being multiple myeloma and its excessive production of non-functional antibodies (M protein).
Andrew Pham   +2 more
doaj   +5 more sources

Upregulated GBP2 exacerbates Parkinson's disease pathogenesis by impairing NIX-dependent mitophagy [PDF]

open access: yesRedox Biology
Parkinson's disease (PD), characterized by dopaminergic neuron loss, still lacks disease-modifying therapies due to incompletely understood mechanisms. Guanylate-binding proteins (GBPs) are well-known immune regulators, but their roles in PD are largely ...
Wenqi Cui, Tianlu Wang, Juan Feng
doaj   +2 more sources

Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells [PDF]

open access: yesBMC Cancer, 2006
Background Nitrogen-containing bisphosphonates (N-BPs) have been designed to inhibit osteoclast-mediated bone resorption. However, it is now accepted that part of their anti-tumor activities is related to interference with the mevalonate pathway. Methods
Weinbaum Carolyn   +6 more
doaj   +3 more sources

Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target [PDF]

open access: yesClinical and Translational Medicine, 2023
Geranylgeranyl diphosphate synthase (GGDPS), an enzyme in the isoprenoid biosynthesis pathway, is responsible for the production of geranylgeranyl pyrophosphate (GGPP).
Molly E. Muehlebach, Sarah A. Holstein
doaj   +2 more sources

Differential requirements of protein geranylgeranylation for the virulence of human pathogenic fungi

open access: yesVirulence, 2019
Protein prenylation is a crucial post-translational modification largely mediated by two heterodimeric enzyme complexes, farnesyltransferase and geranylgeranyltransferase type-I (GGTase-I), each composed of a shared α-subunit and a unique β-subunit ...
Ana Camila Oliveira Souza   +9 more
doaj   +2 more sources

Alendronate prevents angiotensin II-induced collagen I production through geranylgeranylation-dependent RhoA/Rho kinase activation in cardiac fibroblasts

open access: yesJournal of Pharmacological Sciences, 2015
Collagen I is the main component of extracellular matrix in cardiac fibrosis. Our previous studies have reported inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced cardiac fibrosis, while the exact molecular mechanism was still ...
Yang Ye   +6 more
doaj   +3 more sources

Updates on protein-prenylation and associated inherited retinopathies [PDF]

open access: yesFrontiers in Ophthalmology
Membrane-anchored proteins play critical roles in cell signaling, cellular architecture, and membrane biology. Hydrophilic proteins are post-translationally modified by a diverse range of lipid molecules such as phospholipids ...
Sudhat Ashok   +3 more
doaj   +2 more sources

The effects of geranylgeranyl diphosphate synthase inhibitor treatment on osteoblast biology and application in a conditioned media model of myeloma bone disease [PDF]

open access: yesBone Reports
Myeloma bone disease (MBD) is characterized by tumor-induced osteoclast activation with concomitant suppression of osteoblast activity. Nitrogen bisphosphonates (NBPs), including zoledronic acid (ZA), are a mainstay of MBD treatment, due to their anti ...
Molly E. Muehlebach, Sarah A. Holstein
doaj   +2 more sources

Home - About - Disclaimer - Privacy